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Abstract
Background: Spinal cord injuries (SCI) can lead to severe bladder pathologies associated with inflammation, fibrosis, and
increased susceptibility to urinary tract infections. We sought to characterize the complex pathways of remodeling,
inflammation, and infection in the urinary bladder at the level of the transcriptome in a rat model of SCI, using pathways
analysis bioinformatics.
Methodology/Principal Findings: Experimental data were obtained from the study of Nagatomi et al. (Biochem Biophys Res
Commun 334: 1159). In this study, bladders from rats subjected to surgical SCI were obtained at 3, 7 or 25 days post-surgery,
and Affymetrix GeneChipH Rat Genome U34A arrays were used for cRNA hybridizations. In the present study, Ingenuity
Pathways Analysis (IngenuityH Systems, www.ingenuity.com) of differentially expressed genes was performed. Analysis of
focus genes in networks, functional analysis, and canonical pathway analysis reinforced our previous findings related to the
presence of up-regulated genes involved in tissue remodeling, such as lysyl oxidase, tropoelastin, TGF-b1, and IGF-1. This
analysis also highlighted a central role for inflammation and infection, evidenced by networks containing genes such as
CD74, S100A9, and THY1.
Conclusions/Significance: Our findings suggest that tissue remodeling, infection, inflammation, and tissue damage/
dysfunction all play a role in the urinary bladder, in the complex response to SCI.
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Introduction
Spinal cord injuries (SCI) rostral to the lumbar spine can lead to
severe urinary tract dysfunctions in humans, including bladder
areflexia, hyperreflexia, and detrusor-sphincter dyssynergia [1]. In
addition to functional deficiencies, these bladder pathologies
involve changes in tissue morphology such as hypertrophy [2]
and fibrosis [3], as well as significant changes in mechanical
properties [4]. Specifically, chronic neurogenic bladders tend to be
less compliant than normal bladders [3–5]. This loss of compliance
appears to be related to changes in composition of collagen type I
and III within the detrusor tissue, shown by increased ratios of
collagen type III/collagen type I mRNA transcripts within the
detrusor tissue [3].
We have previously utilized a rat model of SCI to investigate the
temporal changes in tissue composition and mechanical properties
in the urinary bladder. We demonstrated that the acute response
of the rat bladder wall tissue (in the first 10 days following injury),
included becoming thicker, and significantly more compliant [6].
In addition, biochemical assays revealed that while the relative
collagen concentration decreased, the relative elastin concentra-
tion of the SCI bladder was significantly greater compared to
normal bladders [7]. Recent results show that the long-term
response (up to 10 weeks after injury) differed from the acute
response, i.e. bladder wall compliance was found to be significantly
greater at 3 and 6 weeks post-SCI when compared to the normal
bladders, but at 10 weeks compliance substantially reduced to near
that of normal bladders [8]. This trend in mechanical compliance
closely paralleled the collagen/elastin ratio. This study showed
that while there are some similarities between acute and chronic
responses of the urinary bladder wall tissue to SCI, the overall
alterations are distinct. Furthermore, this study explained the
discrepancies between the clinical finding of low tissue compliance
and our earlier experimental finding of high compliance [8].
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Other acute remodeling evidence included smooth muscle cell
hypertrophy and changes in smooth muscle bundle orientation
from the longitudinally biased orientation in the normal bladders
to the biphasic (both longitudinal and circumferential) orientation
in the SCI bladders [9]. The molecular mechanisms underlying
the observed changes in tissue composition, including the increase
in elastin content, in the bladder following SCI have not yet been
elucidated. A first step in this was taken by our laboratory by
performing gene microarray analysis and real-time q-PCR on rat
bladders at various time points following SCI [10]. The study
revealed that the mRNA levels for tropoelastin and lysyl oxidase
were as much as eight-fold higher in the bladders of SCI rats as
compared to control animals. This study also demonstrated that
mRNA and protein levels of the cytokines transforming growth
factor-b1 (TGF-b1) and insulin-like growth factor-1 (IGF-1),
known stimulators of elastin synthesis [11–14], were significantly
higher in SCI bladders as compared to those of normal rats. Taken
together, these results suggested that changes in the mechanical
environment of the bladder trigger synthesis of soluble growth
factors by the bladder cells, which induce downstream tissue
remodeling.
The tissue responses to injury and stress are complex and multi-
faceted, and therefore important information can be lost if these
responses are examined in a reductionist fashion, i.e., one gene at a
time. An alternative approach is to examine the response of the
system as a whole, and gene microarray analysis has emerged as a
useful tool with which to interrogate numerous signaling pathways
and biological processes together. To facilitate the analysis of the
gene microarray data, and to relate gene up- and down-regulation
to underlying biological processes, various groups have proposed
using in silico genomics network analysis [15–19], one variant of
which is Ingenuity Pathways Analysis (IPA) (IngenuityH Systems,
www.ingenuity.com).
In the present study, microarray data of bladders from SCI rats,
at different time points after injury, were analyzed using IPA.
Relevant molecular networks and functions that are involved in
the response of bladder tissue to external stress were explored and
modulated. Our findings suggest that tissue remodeling, infection,
inflammation, and damage/dysfunction all play a role in the
complex response to SCI.
Methods
Ethics statement
Data from urinary bladders of rats with experimental SCI were
used in this study. We have chosen the smallest animal species that
is generally accepted as an appropriate model for SCI. Following
SCI, rat bladders show similar behavior to those of humans, and
any phylogenetically lower species would be difficult to simulate
human SCI. All animals were treated and cared for in accordance
with our animal use protocol approved by the Institutional Animal
Care and Use Committee (IACUC) of the University of
Pittsburgh. Spinalized rats were kept in a single occupancy cage
in a climate-controlled facility. The bladders of the spinalized rats
were expressed two times a day to relieve the animals from
overfilling for the first two weeks following surgery or until reflex
voiding emerged. Both laminectomy and bladder harvesting were
performed under halothane anesthesia.
Preparation of samples and microarray analysis
As described in our previous study [10], female Sprague-Dawley
rats (170 g) underwent a complete laminectomy at the T9-T10
spinal level, under halothane anesthesia, according to established
protocols [20]. Bladders were harvested from one normal and
three SCI rats (one each; 3, 7 or 25 days post-surgery) under
halothane anesthesia. The muscle layer of each sample was
dissected, snap-frozen in liquid nitrogen and stored until further
processing.
Total RNA was isolated using TrizolH reagent, and following
the manufacturer’s instructions (Invitrogen, Carlsbad, CA).
Preparation of cRNA, hybridization, and scanning of microarrays
was performed according to established methods [21], following
the manufacturer’s protocols (Affymetrix, Santa Clara, CA). Gene
transcripts expressed by the cells from one bladder in each group
(normal, 3 days, 7 days, and 25 days) were analyzed and compared
using Affymetrix GeneChipH Rat Genome U34A array (Affyme-
trix, Santa Clara, CA). The chips were scanned in a Hewlett-
Packard ChipScanner to detect hybridization signals and the data
were analyzed using Affymetrix GeneChipH Analysis Suite
Software. Statistical tests performed on the data included
determining if genes were significantly present or absent in the
sample (p,0.05), as well as a comparison analysis between
experiment vs. baseline. Gene transcripts for the normal rat
bladder were used as the control for comparison with SCI groups
to determine the change in transcription levels from this baseline,
and if the change could be considered significant, based on a p-
value of the change. A quantitative estimate of the change in gene
expression was given by the signal log ratio, and the fold increase
was calculated as fold increase = 2(log ratio). The microarray data
have been deposited in NCBI’s Gene Expression Omnibus [22]
and are accessible through GEO Series accession number
GSE14096.
Genes that were regulated at least 3.0-fold (both up and down)
were considered significant as in our previous study, and were used
for further analysis with IPA, irrespective of the present/absent
call. In addition, to reduce the number of genes to analyze, a
second measure was used as suggested by IPA. In this method,
genes considered by the software to have not changed significantly
were discarded from the data set based on the change p-value,
which ranges in scale from 0.0 to 1.0. Values close to 0.0 indicate
likelihood for an increase in transcript expression level as
compared to baseline, and values close to 1.0 indicate likelihood
for a decrease. An increase in transcription level was considered
significant at a p-value of 0.003 or lower, while a significant
decrease was considered at a p-value of 0.997 or higher.
Ingenuity Pathways Analysis
The web-based pathways analysis tool IPA (Ingenuity SystemsH,
www.ingenuity.com) was used to identify biological and molecular
networks underlying bladder tissue remodeling after SCI. This
web-based entry tool allows for the mapping of gene expression
data into relevant pathways based on their functional annotation
and known molecular interactions [23–25]. This knowledge
coming from published, peer-reviewed scientific publications is
stored in the Ingenuity Pathways Knowledge Base (IPKB), and is
continuously updated. A molecular network of direct or indirect
physical, transcriptional, and enzymatic interactions between
mammalian orthologs was computed from this knowledge base.
By comparing the imported microarray data with the IPKB, the
list of genes was transformed in a set of relevant networks, focus
genes and canonical pathways were identified, and functional
annotation was performed.
The genes considered to have been differentially regulated to a
significant extent were uploaded into IPA along with the gene
identifiers and corresponding fold change values. Each gene
identifier was mapped to its corresponding gene object in the
IPKB. The genes from the data set were overlaid onto a global
molecular network developed from information contained in the
Pathways in SCI Rat Bladder
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IPKB. In the network analysis, networks of these genes are then
algorithmically generated based on their connectivity. Two genes
are considered to be connected if there is a path in the network
between them. Highly-interconnected networks likely represent
significant biological function, which is defined by an optimized
triangular relationship. Focus genes are defined based on
triangular connectivity, and they are ranked in decreasing order
of triangular connectivity. IPA constructs networks that optimize
for both interconnectivity and number of focus genes under the
constraint of maximal network size.
In the graphical representation of a network, genes or gene
products are represented as nodes, and the biological relationship
between two nodes is represented as an edge (line). All edges are
supported by at least one reference as stored in the IPKB. Human,
mouse, and rat orthologs of a gene are stored as separate objects in
the IPKB, but are represented as a single node in the network. The
intensity of the node color indicates the degree of up- (red) or
down- (green) regulation of a given gene. Nodes are displayed
using various shapes that represent the functional class of the gene
product. Edges are displayed with various labels that describe the
nature of the relationship between the nodes.
The functional analysis of a network identified the biological
functions and/or diseases that were most significant to the genes
in the network, and the functional analysis of the entire data set identified
the biological functions and/or diseases that were most significant
to the data set. The network genes or the genes for the data set,
that were associated with biological functions and/or diseases in
the IPKB were considered for the analysis. Fischer’s exact test was
used to calculate a p-value determining the probability that each
biological function and/or disease assigned to that network or to
the data set is due to chance alone.
Canonical pathways analysis identified molecular pathways from
the IPA library of canonical pathways (part of the IPKB) that were
most significant to the data set. Genes from the data set that were
associated with a canonical pathway in the IPKB were considered
for the analysis. The significance of the association between the
genes from the dataset and the canonical pathway (in the IPKB)
was measured in two ways as described in IPA documentation: 1)
A ratio was calculated of the number of genes from the dataset in a
given pathway divided by the total number of molecules that make
up the canonical pathway; 2) Fisher’s exact test was used to
calculate a p-value determining the probability that there is an
association between the genes in the dataset and the canonical
pathway that cannot be explained by chance alone.
In the present study, only the networks with the highest score,
and which contained relevant genes as based on our previous
study [10] were selected for analysis. They were subsequently
merged to form a single network representing the major
underlying biology of the process. This was followed by functional
analysis on the data set level, and canonical pathway analysis.
Results
DNA microarray results
As described in the previous study by Nagatomi et al. [10], gene
array analysis of bladder mRNA tissue revealed that transcription
levels for over 100 genes in SCI rats were either increased or
decreased at least 3-fold as compared to those of normal rats. In
that prior analysis, special attention was paid to select genes
encoding the extracellular matrix proteins, growth factors linked to
structural protein synthesis, and smooth muscle hypertrophy and
hyperplasia. The expression of tropoelastin and lysyl oxidase
mRNA were 8- and 6-fold higher, respectively, in SCI rats at 3
days as compared to normal rats. At day 7 and 25 the levels
decreased, but they remained at least 3-fold higher than in normal
rats. In addition, mRNA levels for TGF-b1 and IGF-1 in SCI rats
increased to 13- and 5-fold levels respectively, at 3 days post-
injury. IGF-1 levels decreased after this initial up-regulation, but
stayed above 3-fold, whereas TGF- b1 levels stayed as high as 9-
fold at both day 7 and day 25.
Up-regulation of tropoelastin and lysyl oxidase was further
confirmed and quantified at the mRNA level using total RNA
collected from three to four bladders each of normal and post-SCI
(3 days, 7 days, and 25 days) rats and TaqMan analysis according
to the standard protocols with the Mx3000P qPCR apparatus
(Stratagene, La Jolla, CA), as described previously [10]. mRNA
expression for tropoelastin and lysyl oxidase was found to be
significantly higher at 3 and 7 days post-SCI as compared to
normal, and returned to normal levels at 25 days. Also,
concentrations of TGF-b1 and IGF-1 in the bladder protein
samples were quantified using a commercially available immuno-
assay kit and following manufacturer’s instructions, as described in
[10]. This analysis confirmed that both transcription and
translation were up-regulated as a result of SCI.
In our previous study, gene expression arrays were utilized as a
first pass to identify potential target genes. The present study
further explores those datasets using IPA.
Genes and gene networks induced post-SCI
The microarray data were analyzed using IPA for all three time
points, comparing SCI rats to a non-manipulated control. From
each data set, 558 (day 3), 361 (day 7), and 395 (day 25) genes,
respectively, were deemed to be expressed differentially and were
uploaded into IPA accordingly. We first examined the most
relevant focus genes and their respective networks (score .27).
The most significantly evoked networks for each time point post-
SCI, including the top biological functions underlying the
networks, can be found in the Supplementary Tables S1, S2, S3.
To identify all relevant genes based on both the fold-change and
the network score, the most highly-scored networks for each time
point were merged and investigated separately (See Supplemen-
tary Figures S1, S2, S3). At day 3, the networks that received the
highest scores (seven total) suggested important changes in gene
expression. Tables 1–2 show a summary of all genes that were
found to be of interest based on their fold change value, or on their
central location. The numbers can also be found in Figure 1,
where one network from each time point is shown, emphasizing
important genes. These networks represent examples of remod-
eling, damage, and inflammation/infection, respectively.
Evidence for remodeling post-SCI based on gene
network analysis
The importance of the molecules that are important in
remodeling, i.e. lysyl oxidase (LOX), tropoelastin (ELN), TGF-
b1, and IGF-1, as established by Nagatomi et al. [10] were
confirmed in the present study. TGF-b1 and IGF-1 both play
prominent roles in many cellular processes, including tissue
remodeling, growth, and development. They both occupy a
central position in the networks, and hence are important players
in the pathological process, although their expression (in fold-
change) was not as high as compared to some other molecules
(Table 1). IGF-1 is a very central molecule at day 3 and day 7 post-
SCI, but it disappeared at day 25. The most significant network at
day 3 post-SCI, with 30 focus genes and a score of 49, suggests an
indirect or not yet established relation between TGF-b1 and
tropoelastin (Figure 1a). A previous study found that human TGF-
b1 protein increases the activity of rat LOX protein in ovary
granulosa cells in a dose-dependent manner [26], but this
Pathways in SCI Rat Bladder
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relationship has not been explored in the bladder or in the setting
of SCI. TGF-b1 has also been shown to have significant effect on
collagen organization in collagen gels seeded with bladder smooth
muscle cells [27,28].
The network analysis confirms the up-regulation of tropoelastin
following SCI as compared to normal tissue, though this up-
regulation does not occur to a very large extent as compared to
other transcripts (notice the light red color in Figure 1). Our
previous studies have confirmed the significance of increased
elastin concentrations in rat bladders at different time-points after
SCI [8,29]. Tropoelastin appears in the most significant networks
at day 3 and 7, but not at day 25. At day 25, tropoelastin appears
in network 11, which contains mainly the following functions:
‘‘Cellular growth and proliferation’’, ‘‘Cell cycle’’, and ‘‘Cellular
movement’’. In this network, complement component 3 (C3),
which plays a central role in the activation of complement system,
is the most prominent molecule, with a fold change of 36.8.
Recently, it has been established that C3 plays an important role
in the inflammation and secondary injury of the spinal cord
following SCI, although little is still known about its exact role
[30].
The protein encoded by the LOX gene is an extracellular
copper-containing enzyme that initiates the cross-linking of
collagens and elastin. In the networks, LOX shows a direct
relation with elastin (Figure 1), but in addition, it has been shown
to be involved in the organization of collagen fibrils [31]. Over-
Table 1. List of relevant genes up-regulated by SCI.
ID No. Gene name Gene description and relevant information
Fold change
Day 3
Fold change
Day 7
Fold change
Day 25
S66184_s_at,
rc_AA875582_at
1 LOX* lysyl oxidase, crosslinking of collagens and elastins 21.1 3.5
J04035_at 2 ELN tropoelastin 8.6 3.0 3.5
X52498cds_at 3 TGFb1 involved in multiple functions and diseases 13.0 9.2 9.2
X13044(cds)_(g)_at 4 CD74* cytokine binding, major histocompatibility complex (MHC)
class II molecule, antigen presentation
21.1 12.1 26.0
U65217_i_at X56596_at 5 HLA-DQB2* major histocompatibility complex (MHC) class II molecule,
antigen presentation
19.7 14.9 8.0
L18948_at 6 S100A9 damage-associated molecular pattern (DAMP) molecule 9.2 207.9 194
rc_AA957003_at 7 S100A8 damage-associated molecular pattern (DAMP) molecule 14.9 13.0
X02002_at 8 THY1 surface receptor on T-lymphocytes 19.7 24.3 7.0
S74351_s_at
S81478_s_at
U02553cds_s_at
9 DUSP1* involved in inflammatory response 17.1 9.8
M65149_at
rc_AI045030_s_at
10 CEBPD involved in inflammatory and immune responses 14.9 9.2 4.9
M24067_at 11 Serpine1 serum protease inhibitor, involved in may pathological processes 13.9 4.3
D00698_s_at 12 IGF1 involved in multiple processes and diseases 4.9 3.7
M29866_s_at 13 C3 activation of complement system, immune response to bacteria 19.7 36.8
*Gene is represented in the microarray set with multiple identifiers.
doi:10.1371/journal.pone.0005852.t001
Table 2. List of relevant genes down-regulated by SCI.
ID No. Gene name Gene description and relevant information
Fold change
Day 3
Fold change
Day 7
Fold change
Day 25
J03179_(g)_at 14 DBP* D site of albumin promoter binding protein,
transcription activator and regulator
245.3 229.9 255.7
Z83757mRNA_(g)_at 15 GHR* growth hormone receptor 221.1 24.9
J03819_at 16 THRB thyroid hormone receptor beta 259.7 234.3
AF007836_at 17 RIMS1 synaptic vesicle protein, regulating synaptic
membrane exocytosis
239.4
X51529_at 18 PLA2G2A phospholipase A2, group IIA 234.3
U17837cds_at 19 PRDM2 PR domain containing 2, transcription regulator,
tumor suppressor gene
245.3
X53087cds_at 20 IL4 interleukin-4, cytokine, immune response 216.0
M31837_at,
rc_AI009405_s_at
21 IGFBP3* insulin-like growth factor binding protein 3 234.3
*Gene is represented in the microarray set with multiple identifiers.
doi:10.1371/journal.pone.0005852.t002
Pathways in SCI Rat Bladder
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expression of LOX in a rat dermal wound healing model resulted
in significantly enhanced mechanical strength of the wound site,
indicating increased cross-linking of the extracellular matrix[31].
Evidence for inflammation post-SCI from gene network
analysis
Nagatomi et al. focused entirely on tissue remodeling and the
genes involved in that process [10]. The present IPA analysis
revealed that processes that are related to inflammation and
infection are also highly prevalent in the data sets, especially at 25
days post-SCI. This led to our additional focus on the networks
that showed highly up-regulated genes that are involved in
inflammation and infection.
The most remarkable sign of tissue damage and inflammation is
the presence of S100A9 (S100 calcium binding protein A9) as early
as day 3, but with fold change values around 200 at day 7 and day
25 (Table 1, Figure 1b). Phagocytic S100 proteins are calcium
binding proteins that are a well-known example of damage-
associated molecular pattern (DAMP) molecules, which mediate
inflammatory responses and recruit inflammatory cells to sites of
tissue damage [32]. S100A8 (also named calgranulin A; myeloid-
related protein 8, MRP8), and S100A9 (calgranulin B; MRP14)
are found in granulocytes, monocytes, and early differentiation
stages of macrophages. They are found at high concentrations in
inflamed tissue, where neutrophils and monocytes belong to the
most abundant cell types. They exhibit pro-inflammatory effects in
Figure 1. A single network for each time point post-SCI showing relevant genes. A) The first network of day 3 post-SCI with a maximum
score of 30. This network clearly shows the direct relation between elastin and LOX, and an indirect relation between TGF-b1 and elastin. B) The
second network of day 7 post-SCI showing the highly up-regulated damage-associated genes S100A8 and S100A9. C) The second network of day 25
post-SCI showing the immune response associated genes CD74 and HLA-DQB2. An asterisk (*) indicates that a given gene is represented in the
microarray set with multiple identifiers.
doi:10.1371/journal.pone.0005852.g001
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vitro at concentrations found at sites of inflammation in vivo.
Expression of these proteins can also be induced in keratinocytes
and epithelial cells under inflammatory conditions. Secretion of
S100A8/S100A9 is induced during contact of phagocytes with
inflamed endothelium [32].
The high up-regulation of CD74, HLA-DQB, and THY1
(Table 1, Figure 1c) suggests infiltration of inflammation-related
cells, such as T lymphocytes and B lymphocytes, monocytes, and
macrophages. As found from IPKB, CD74 and HLA-DQB2 are
major histocompatibility complex (MHC) class II molecules. They
are associated with the cell surfaces of B and T lymphocytes.
CD74’s main molecular function is cytokine binding, and both
CD74 and HLA-DQB are involved in the antigen presentation
canonical pathway and in the immune response. CD74 is shown to
be present in the rat urothelium (the endothelial lining of the
urinary bladder) [33]. CD74 bladder immunostaining, and total
amount of bladder CD74 protein and mRNA, are increased in an
acute model of bladder inflammation [33]. THY1 is a surface
receptor on T-lymphocytes. Interestingly, THY1 is also involved
in regulating collagen type I, smooth muscle alpha actin, and
TGF-b1 in the renal glomerulus from rats exhibiting glomerulo-
nephritis [34].
DUSP1 (dual specificity phosphatase 1, synonym: MKP-1) is
highly up-regulated at day 3 and day 25 (Table 1). It belongs to the
MAPK (mitogen-activated protein kinase) phosphatase family, and
dephosphorylates and inactivates MAPKs. It is involved in various
signal transduction mechanisms and is known to be part of the
inflammatory response. DUSP1 is suggested to play an important
role in the human cellular response to environmental stress, as well
as in the negative regulation of cellular proliferation. The
activation of DUSP1 seems to counterbalance the inflammatory
response to PAR (protease-activated receptors) activation by
avoiding prolonged activation of p38 MAPK and increased
cytokine production in the rat urinary bladder, which was
revealed using IPA [35]. Studies using cultured immortalized
macrophages provided compelling evidence indicating that MKP-
1 deactivates p38 and JNK, thereby limiting pro-inflammatory
cytokine biosynthesis in innate immune cells exposed to microbial
components; this effect was confirmed in vivo using MKP-1-
deficient mice [36]. DUSP1 appears to be a major feedback
regulator of the innate immune response, and to play a critical role
in preventing septic shock and multi-organ dysfunction during
pathogenic infection [36]. Importantly, DUSP1 increases migra-
tion of smooth muscle cells to soluble collagen protein(s) through
chemotaxis [37], and hence is also involved in the remodeling
process.
Serpine1 is highly up-regulated at day 3, but decreases after
that. Serpine1 is a type of serine protease inhibitor (serine
protease inhibitor clade E, member 1; also called plasminogen
activator inhibitor 1, PAI-1), a type of enzyme that plays a
central role in various pathological processes including coagu-
lation, fibrinolysis, malignancy, and inflammation [38,39]. In
several in vitro studies, Serpine1 has been shown to regulate, and
to be regulated by TGF-b1, and thus its elevated expression in
our study may be a further indicator of increased TGF-b1
expression. More specifically related to the urinary tract and
fibrosis, both Serpine1 and TGF-b1 are involved in diabetic
nephropathy [40], and in the context of smooth muscle cells,
TGF-b1 protein is involved in expression of human Serpine1
mRNA in smooth muscle cells from myometrium of human
females [41].
Another important gene at day 3 is CEBPD. The protein
encoded by the CEBPD gene (Table 1) (CCAAT/enhancer
binding protein (C/EBP), delta) is a transcription factor which is
important in the regulation of genes involved in immune and
inflammatory responses [42].
Down-regulated genes
In addition to the up-regulated genes, the analysis shows some
remarkable, high fold-change values for down-regulated genes
(Figure 1, Table 2). However, most of these genes are unrelated to
inflammation or remodeling. DBP (D site of albumin promoter
binding protein), a transcription activator and regulator, is the only
gene that is down-regulated at all three time-points (Figure 1, Table 2).
THRB (thyroid hormone receptor beta) is down-regulated at day 3
and 7 post-SCI, and GHR (growth hormone receptor) at day 7
(Figure 1b) and 25. Down-regulation of GHR implies that growth
and proliferation are inhibited, and that apoptosis and cell death are
prevalent. The cytokine interleukin 4 (IL-4) is also down-regulated.
IL-4 is produced by activated T cells, and is involved in inflammation,
fibrosis, and multiple immune diseases. The down-regulation of IL-4,
a canonical Th2 cytokine, suggests that Th1 pathways might
predominate in this setting. For completeness, Table 2 shows the
relevant genes with high negative fold-change values.
Functions
Functional analysis of the three time points in the data set
together reveals three important classes of functions, i.e. functions
that are related to (1) remodeling, (2) inflammation, and tissue
damage, (3) infection, and (4) bladder- or SCI-specific functions
(Figure 2). More specifically, at day 3 after injury, remodeling and
cellular processes prevail (Figure 2a), whereas at day 7 neurological
disease, renal and urological disease, and inflammatory disease
and immune response functions are initiated (Figure 2b–c). At day
25, inflammatory disease and immune response transcripts appear
to be highly important (Figure 2c). The important functions,
organized per time point and highlighting the important ones, are
shown in Supplementary Figure S4.
For each function, we delved deeper into the specific genes that
were involved, focusing on relevant cell types such as fibroblasts
and smooth muscle cells. At all time points, DUSP1, IGF1, TGF-
b1, Serpine1 are involved in growth, size and proliferation of
connective tissue cells and (smooth) muscle cells. At 25 days,
DUSP1 and IGF1 are involved in cell death and apoptosis of
kidney cells, and failure and damage of the kidney. Also at the 25
day time point, the injured bladder tissue appears to undergo
extensive activation, infiltration, and migration of inflammatory
cells (‘‘immune response’’). Additionally, tropoelastin is involved in
proliferation of muscle cells at day 3 and 7. Chemotaxis of
monocytes and lysyl oxidase are involved in growth and
proliferation of fibroblast cell lines at 3 days.
Canonical pathways
At 3 days post-SCI, canonical pathways that involve synaptic
processes are highly prevalent, presumably highlighting the effect
of spinal cord transection on the nervous processes in the bladder.
IGF signaling is present at all three time points. At day 7, pathways
that are associated with inflammation appear, and at day 25, in
addition to pathways associated with inflammation, those that
suggest infection are visible. The canonical pathways for each time
point are shown in Supplementary Figure S5.
Discussion
Significance and relevance of bladder inflammation after
SCI
It is well-established that inflammation is a central driver of the
physiology of people with spinal cord injuries, and it is apparent
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that inflammation has both beneficial and detrimental functions
[43–45]. Traumatic central nervous system (CNS) injury can
trigger severe systemic effects that lead to pathological autoim-
munity, including the activation of T and B lymphocytes [45–48].
The bladder appears to be one of the organs that suffer from these
systemic effects, as indicated by the present pathway analysis
Figure 2. Functional analysis of all time points combined. Functions are listed by class: A) Functions related to remodeling; B) Functions
related to inflammation, tissue damage, and infection; C) Bladder- or SCI-specific functions. The negative value of the log of the p-value is plotted for
each function. Black is day 3, dark gray is day 10, and light gray is day 25.
doi:10.1371/journal.pone.0005852.g002
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results. Deveaud et al. demonstrated that both lymphatic nodules
and diffuse aggregates of lymphocytes were present in the lamina
propria layers of many bladder tissue specimens, indicating
inflammation and/or infection of the tissue [3]. This inflammation
and infection are attributed to urine retention and catheterization.
Inflammation is further related to connective tissue remodeling;
the primary lesion or stimulus for alteration of connective tissue
expression is not inflammatory, but in patients with conditions
involving recurrent or chronic urinary tract infections and
inflammation, there could be a secondary or additive effect due
to cytokine expression.
Our present study suggests an important role for inflammation
in the bladder after experimental SCI in the absence of known
bacterial infection, perhaps related to direct injury to the spinal
cord. The temporal process of inflammation and the differences
between time points could be explained by differences in urine
expression. The bladders were manually expressed twice daily up
to two weeks post-injury, until the moment that reflex voiding
started. In the first period, inflammation could be a result of
bladder over-distension due to overfilling, whereas by the 25 day
time point, hyper-contraction could be responsible for inducing a
different inflammatory cascade. Few studies have been performed
on the relationship between inflammation and the urinary bladder
after SCI, except for inflammation as a result of bacterial infection.
Results from a study on urinary bladder biopsies from SCI patients
demonstrated no correlation between the number of bladder
infections per year and the histopathology of the urinary bladder
mucosa. In this study, 67.0% of the patients showed a chronic type
of inflammation, and 24.5% showed a sub-acute type of infection,
whereas all patients were free of clinical signs of infections. The
inflammatory cell infiltrate was shown to be located solely in the
lamina propria, together with fibrosis [49]. This study corrobo-
rates our results, which suggest that a different source for
inflammation than bacterial infection alone must exist.
Double identifiers
From the IPA analysis, we found a much higher up-regulation
of lysyl oxidase than that reported in our previous study [10]. This
transcript was elevated as much as 21 fold as compared to normal
bladder at 3 days post-SCI, whereas a value of 8.5 was reported
previously. A closer look into the data set revealed that LOX was
represented in the microarray set with two identifiers
(‘‘S66184_s_at’’ and ‘‘rc_AA875582_at’’, Table 1). For day 7
and day 25, the analysis showed the same extent of up-regulation
as before, i.e. 3.5 and 2.8 respectively (S66184_s_at), and no
significant up-regulation for the other identifier (rc_AA875582_at).
In addition to unique probe sets, the Affymetrix GeneChipH
consists of non-unique probe sets that recognize multiple
alternative transcripts from the same gene (probe set type, ‘‘_a’’),
and probe sets with common probes among multiple transcripts
from separate genes (‘‘_s’’ suffix) (Affymetrix, ‘Array Design and
Performance of the GeneChipH Rat Expression Set 230’). All
genes with double identifiers are indicated in Table 1–2 with an
asterisk.
Significance of IPA
The sheer volume of data generated in typical microarray
experiments often thwarts attempts at discerning central drivers of
a given process. Ingenuity Pathways Analysis and similar in silico
analysis tools have the potential to identify mechanisms behind
experimental observations of changes in gene expressions, in
different organ systems. To our knowledge, the present study is the
first to elucidate genetic pathways in neuropathic bladders. Other
urological applications involve the role of PARs in cystitis [35] (as
described above), neuropathic bladder smooth muscle cells in
culture [50], and diabetic bladders [51]. Dozmorov et al. [50]
sought to identify candidate genes and pathways that are
associated with increased thickness of smooth muscle layers
observed in neuropathic bladder and the elevated cell proliferation
observed in cultured neuropathic bladder smooth muscle cells as
compared to their normal counterparts. Their analysis, based on a
small set of 16 genes, identified the FGF, PTEN, and integrin
signaling pathways to be involved in regulating bladder smooth
muscle cell growth and proliferation and in the pathological
development of the neuropathic cells. Hipp et al. [51] carried out
pathways-based analysis, using a different technique (Expression
Analysis Systematic Explorer, EASE, free software), of gene
expression changes in urogenital smooth muscle from diabetic
animals before the onset of physiologically significant diabetic
complications, to identify and define diabetes induced, organ-
specific smooth muscle responses. Interestingly, they found up-
regulation of various cytokines and inflammatory mediators in
both bladder and corporal smooth muscle tissue after experimen-
tally induced diabetes. Diabetes, like SCI, is a systemic disorder
that is not initiated in the bladder but that significantly affects this
organ.
Limitations
The findings presented herein must be evaluated in the context
of several limitations. Our method of sorting the data and
eliminating genes from the data might have increased the risk of
including false positives in the final data set that was uploaded to
IPA. The present/absent call was ignored because of the low n-
number, and because the level of statistical significance is not
necessarily related to the level of biological significance. The
commonly accepted and generally used cut-off fold-change value
of 2 [25] was increased to 3 to decrease the number of genes to be
analyzed and to decrease the likelihood of possible false-positives.
Further limitations are related to the IPKB. It is a manually
curated database that draws on the scientific literature, and the
attribution of functions to gene sets is therefore somewhat
subjective. As the literature evolves, so are the attributed pathways
likely to evolve. The information in the IPKB, and the relations
found in this study are not specific for bladder tissue, or for a
smooth muscle containing tissue in general. However, the analysis
gives a good indication of relevant processes by drawing parallels
with knowledge obtained from other organ systems and in vitro
studies. In addition, the information that is specifically found for
smooth muscle cells, relates to vascular smooth muscle cells, which
are known to differ from bladder smooth muscle cells in different
aspects.
Another limitation in our study is that the tissue used for the
gene array analysis contained other cell types in addition to
smooth muscle cells, such as neural cells. In this study, it was
impossible to distinguish between effects coming from the different
tissue types, though the changes in expression of genes
characterized as coming from an inflammatory infiltrate likely
delineate the influx of such cells into the bladder. Some studies
have carried out laser capture microdissection in order to obtain
more focused tissue sources [52], but our intent was to examine
the overall response of the bladder to SCI.
The present study did not validate the IPA results by q-PCR or
immunoassays. However, the presence of tropoelastin and lysyl
oxidase at the mRNA level, and TGF-b1 and IGF-1 at the protein
level was quantified in our previous study [10]. We envision that
the present results will be used as a guideline for future studies, and
q-PCR or immunoassays should be performed before further
conclusions are drawn from them.
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Conclusions
The present study follows up on earlier results that showed that
several genes related to structural protein synthesis, smooth muscle
hypertrophy, and hyperplasia were up-regulated significantly in
rat bladder tissue as a result of SCI [10]. Of special interest in this
up-regulated set of transcripts were tropoelastin, lysyl oxidase,
IGF-1, and TGF-b1, which were all significantly up-regulated as
compared to normal rat bladder at all three time points post-SCI.
The goal of this study was to identify mechanistic targets in the
form of pathways modulated by SCI; further work in additional
animals is needed in order to establish the role of these pathways in
the pathology observed in this animal model. The present
pathways analysis corroborates the original microarray results
[10] on the significance of remodeling in bladder tissue after SCI,
and it reveals a greater role for local and systemic inflammation
than had been previously appreciated in this setting. Additionally,
our study suggests that the alarm/danger response [53] may play
an early, central role post-SCI. We suggest that the coupled use of
DNA microarrays and pathways analysis techniques will help
define molecular milestones associated with the initiation,
development, and progression of bladder complications accom-
panying disorders such as SCI.
Supporting Information
Table S1 Focus genes and top functions resulting from the
network analysis, per network, at 3 days post-SCI.
Found at: doi:10.1371/journal.pone.0005852.s001 (0.02 MB
PDF)
Table S2 Focus genes and top functions resulting from the
network analysis, per network, at 7 days post-SCI
Found at: doi:10.1371/journal.pone.0005852.s002 (0.01 MB
PDF)
Table S3 Focus genes and top functions resulting from the
network analysis, per network, at 25 days post-SCI
Found at: doi:10.1371/journal.pone.0005852.s003 (0.02 MB
PDF)
Figure S1 Merged view of the first five networks for three days
post-SCI. Arrows indicate the most relevant genes. An asterisk (*)
indicates that a given gene is represented in the microarray set
with multiple identifiers. The gene numbers are also listed in
Table 1–2.
Found at: doi:10.1371/journal.pone.0005852.s004 (1.41 MB TIF)
Figure S2 view of the first six networks for ten days post-SCI.
Arrows indicate the most relevant genes. An asterisk (*) indicates
that a given gene is represented in the microarray set with multiple
identifiers. The gene numbers are also listed in Table 1–2.
Found at: doi:10.1371/journal.pone.0005852.s005 (2.17 MB TIF)
Figure S3 Merged view of the first seven networks for 25 days
post-SCI. Arrows indicate the most relevant genes. An asterisk (*)
indicates that a given gene is represented in the microarray set
with multiple identifiers. The gene numbers are also listed in
Table 1–2.
Found at: doi:10.1371/journal.pone.0005852.s006 (2.44 MB TIF)
Figure S4 Functional analysis of the complete data set. The
most significant and relevant functions are listed for each time
point post-SCI. The negative value of the log of the p-value is
plotted for each function. A) Three days post-SCI. B) Ten days
post-SCI. C) 25 days post-SCI.
Found at: doi:10.1371/journal.pone.0005852.s007 (0.12 MB
PDF)
Figure S5 Significant canonical pathways for each time point
post-SCI. The negative value of the log of the p-value is plotted for
each pathway, together with the signal log ratio value (ratio). A)
Three days post-SCI. B) Ten days post-SCI. C) 25 days post-SCI.
Found at: doi:10.1371/journal.pone.0005852.s008 (0.13 MB
DOC)
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